DexCom, Inc. Profile Avatar - Palmy Investing

DexCom, Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, a…
Medical - Devices
US, San Diego [HQ]
Lobbying · US Senate · Influence

Lobbying Analysis

FY Quarter Lobby Expense [in mil. $] Filing Report Time
2024 3 2 LDA-2 Oct. 21, 2024, 6:24 p.m.
2024 3 5 LDA-2 Oct. 21, 2024, 4:41 p.m.
2024 2 5 LDA-2 July 22, 2024, 3:45 p.m.
2024 1 5 LDA-2 April 22, 2024, 2:32 p.m.
2023 4 5 LDA-2 Jan. 22, 2024, 5:59 p.m.
End of DXCM's Analysis
CIK: 1093557 CUSIP: 252131107 ISIN: US2521311074 LEI: - UEI: -
Secondary Listings
DXCM has no secondary listings inside our databases.